Drug profile · INN
hydroxocobalamin
COBAL-B12
hydroxocobalamin (COBAL-B12) is a cyanide sequestering agent. Associated with Pfizer Australia Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — hydroxocobalamin
- US status
- approved
- Class
- Various (V03)
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
hydroxocobalamin (COBAL-B12) is a cyanide sequestering agent. Associated with Pfizer Australia Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Cyanide sequestering agent
Primary target: Cyanide
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is hydroxocobalamin?
hydroxocobalamin (COBAL-B12) is a cyanide sequestering agent. Associated with Pfizer Australia Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for hydroxocobalamin?
COBAL-B12 is a marketed brand name for hydroxocobalamin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of hydroxocobalamin?
hydroxocobalamin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.